You are here : Home
Seamless Drug Development from Bench to Market

CARBOGEN AMCIS is a leading provider of drug development and commercialization services to the pharmaceutical and biopharmaceutical industries, at all stages of drug development. The integrated services of CARBOGEN AMCIS provide innovative, timely and safe drug development solutions that allow customers to make the best use of their available resources.

CARBOGEN AMCIS’ focus is on supporting the development process from bench to market. The breadth of capabilities spans from contract chemical process research and development to the supply of Active Pharmaceutical Ingredients (APIs) and drug products for preclinical studies, clinical trials and commercial use.

CARBOGEN AMCIS also conducts the development and supply of highly potent APIs to an activity level below 1.0 µg/m³.

CARBOGEN AMCIS’ business philosophy includes intensive analytical support for all customer projects, which is reflected in a broad variety of analytical tools and techniques. This also includes an interactive Laboratory Information Management System (LIMS) to enhance collaboration. The interactive, state-of-the-art IT platform LIMS provides customers live online access to analytical data taking into account that all customer information stays secure.

With its ongoing review and implementation of new technologies (micro-reactors, expansion of chromatography techniques and crystallization), CARBOGEN AMCIS stands at the forefront of chemical service providers and helps its customers to reduce the time, costs and risks associated with drug development.

With our strategically built business platforms, our customers benefit from the most efficient, flexible, collaborative and seamless experience possible.

Our work helps clients make critical decisions more efficiently and progresses drug candidates through the development pipeline with greater speed.

10 September 2015
CARBOGEN AMCIS Passes Successful Inspection by Swissmedic

3 October 2014
CARBOGEN AMCIS CEO Mark Griffiths Appointed to Dishman Board of Directors

5 August 2014
CARBOGEN AMCIS Expands Operations in Switzerland

Bio 2 Business